CRISPR Gene Editing Newsletter
Issue #27March 9, 20267 studies

Gene therapy reduces cholesterol by 52% for 6 months with single injection

This week brought major advances in gene editing—from treating inherited diseases to understanding how cells work. Here's what caught our attention.

🧬 Single gene therapy injection cuts cholesterol in half

  • 6 patients with familial hypercholesterolemia got a single IV dose of YOLT-101, a gene therapy that uses base editing to permanently disable the PCSK9 gene

  • At the highest dose (0.6 mg/kg), patients saw their LDL cholesterol drop by 52.3% and PCSK9 protein levels fall by 74.4%—and these reductions lasted the full 24 weeks of follow-up

  • No serious side effects occurred, just temporary infusion reactions and mild liver enzyme elevations that resolved on their own

Why it matters: This could be a one-time treatment for people with genetic high cholesterol who can't control it with current medications. The base editing approach permanently rewrites DNA without the large deletions that other gene editing tools sometimes cause.

🏆 Top 0.1% journal 🔗 Nature medicine 🗓️ Mar 3

Key Findings

🎯 New tool maps gene regulation at single-letter precision

  • Researchers developed a method to identify exactly which DNA letters control gene expression by reading the actual genetic changes at target sites, rather than inferring them indirectly

  • Testing this on the CD19 gene (a target for leukemia immunotherapy), they pinpointed specific transcription factor binding sites that are crucial for the gene's activity

  • When they mutated the MYB and PAX5 binding sites, cancer cells became resistant to CAR-T cell therapy—revealing how genetic variants could help tumors escape treatment

💡 This nucleotide-level precision could help predict which genetic variants affect disease and treatment response.
🥈 Top 2% journal 🔗 Nature communications 🗓️ Mar 2

🔬 Base editing avoids dangerous DNA deletions in cholesterol gene

  • Scientists used cytosine base editing to introduce stop signals into the LPA gene (which makes lipoprotein(a), a heart disease risk factor) in mice

  • This approach produced sustained reductions in circulating apolipoprotein(a) while causing large DNA deletions in less than 4% of cases

  • In contrast, traditional CRISPR/Cas9 cutting resulted primarily in large deletions, which could be harmful

💡 Base editing may offer a safer path for treating genetic causes of heart disease than traditional gene cutting approaches.
🥈 Top 2% journal 🔗 Mol Ther 🗓️ Mar 5

🧪 CRISPR kill switch leaves genetic traces behind

  • Engineered E. coli bacteria designed with a CRISPR kill switch to prevent environmental spread showed escape rates of 10^-1.6 to 10^-1 when measured by DNA detection, despite colony growth rates of only 10^-6.2

  • The target genes remained detectable and protected inside intact cell membranes for hours after biocontainment activation, though they degraded over days in river water

  • This means genetic material from biocontained organisms could persist in the environment longer than expected

💡 Biocontainment strategies need to account for DNA persistence, not just whether organisms can grow and reproduce.
🥈 Top 2% journal 🔗 Environmental science & technology 🗓️ Mar 2

🩺 Portable CRISPR test detects multiple STIs in one assay

  • A multiplexed CRISPR diagnostic detected gonorrhea with 80% sensitivity, chlamydia with 73% sensitivity, syphilis with 82.5% sensitivity, and herpes with 94.4% sensitivity in 900 clinical samples

  • The test also identified a specific antibiotic resistance mutation (gyrA S91F) in gonorrhea with 63.1% overall sensitivity, reaching 85.7% in genital samples

  • Each pathogen was detected using two independent DNA regions and different fluorescent signals, with results available at the point of care

💡 This portable platform could enable rapid, resistance-informed STI diagnosis in resource-limited settings where lab access is limited.
🥇 Top 1% journal 🔗 The Lancet. Microbe 🗓️ Mar 6

🔬 Mapping 80,000+ mutations reveals essential protein interaction sites

  • Scientists used base editing to mutate 7,293 short linear motifs (protein binding sites) with 80,473 different mutations across the human genome in HAP1 cells

  • They identified 450 known and 264 predicted motifs that are required for normal cell growth, including many that don't belong to existing categories

  • The results were highly reproducible in a second cell line (RPE1), with differences mainly due to cell-type-specific gene requirements

💡 This proteome-wide map reveals hundreds of uncharacterized protein interactions that are essential for cell survival.
🥇 Top 1% journal 🔗 Nature structural & molecular biology 🗓️ Mar 6

🧬 Natural CRISPR system controls gene expression without cutting DNA

  • Researchers discovered that some bacteria use dead Cas12f proteins (that can't cut DNA) paired with specialized sigma factors to turn genes on in response to guide RNAs

  • This natural system can activate transcription without requiring traditional promoter sequences, with transcription starting at sites defined solely by the distance from the Cas12f binding location

  • The discovery reveals that bacteria evolved their own version of CRISPR activation technology millions of years before scientists invented it

💡 Nature's own CRISPR activation system could inspire new tools for precisely controlling gene expression in biotechnology.
🏆 Top 0.1% journal 🔗 Nature 🗓️ Mar 4

Implications

Gene editing is rapidly moving from experimental tool to practical medicine, with new therapies showing sustained effects and safer approaches emerging. Meanwhile, discoveries of natural CRISPR systems and precise mapping techniques are expanding our understanding of how genes are controlled—setting the stage for even more targeted treatments.

Studies in this issue

Primary sources used for this newsletter.

  1. Gene editing treatment for inherited high cholesterol: early human trial
    main storyNature medicine2026-03-03PMID 41776075
  2. Precise DNA editing of LPA gene in modified mice prevents large DNA losses
    key findingMolecular therapy : the journal of the American Society of Gene Therapy2026-03-05PMID 41782368
  3. Genetic markers can still be found in engineered microbes controlled by a CRISPR kill switch
    key findingEnvironmental science & technology2026-03-02PMID 41766140
  4. A comprehensive map showing how protein interaction sites depend on each other across all proteins
    key findingNature structural & molecular biology2026-03-06PMID 41792279